138 related articles for article (PubMed ID: 36401483)
41. Efficacy and Safety of Carboplatin and Etoposide Combination Chemotherapy for Extrapulmonary Neuroendocrine Carcinoma: A Retrospective Case Series.
Imai H; Shirota H; Okita A; Komine K; Saijo K; Takahashi M; Takahashi S; Takahashi M; Shimodaira H; Ishioka C
Chemotherapy; 2016; 61(3):111-6. PubMed ID: 26636658
[TBL] [Abstract][Full Text] [Related]
42. FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3.
Hentic O; Hammel P; Couvelard A; Rebours V; Zappa M; Palazzo M; Maire F; Goujon G; Gillet A; Lévy P; Ruszniewski P
Endocr Relat Cancer; 2012 Dec; 19(6):751-7. PubMed ID: 22940375
[TBL] [Abstract][Full Text] [Related]
43. Neoadjuvant chemotherapy before definite operative approach for women with advanced-stage epithelial ovarian cancer.
Wang PH
Taiwan J Obstet Gynecol; 2018 Oct; 57(5):623-624. PubMed ID: 30342639
[No Abstract] [Full Text] [Related]
44. Urgent need for consensus: international survey of clinical practice exploring use of platinum-etoposide chemotherapy for advanced extra-pulmonary high grade neuroendocrine carcinoma (EP-G3-NEC).
Lamarca A; Frizziero M; Barriuso J; McNamara MG; Hubner RA; Valle JW
Clin Transl Oncol; 2019 Jul; 21(7):950-953. PubMed ID: 30506132
[TBL] [Abstract][Full Text] [Related]
45. Small cell neuroendocrine carcinoma of the ethmoid sinuses presenting with generalized seizure and syndrome of inappropriate antidiuretic hormone secretion: a case report and review of literature.
Ma AT; Lei KI
Am J Otolaryngol; 2009; 30(1):54-7. PubMed ID: 19027514
[TBL] [Abstract][Full Text] [Related]
46. Neuroendocrine Cancer, Therapeutic Strategies in G3 Cancers.
Rinke A; Gress TM
Digestion; 2017; 95(2):109-114. PubMed ID: 28161703
[TBL] [Abstract][Full Text] [Related]
47. Feasibility and efficacy of combined cisplatin and irinotecan chemotherapy for poorly differentiated neuroendocrine carcinomas.
Nakano K; Takahashi S; Yuasa T; Nishimura N; Mishima Y; Sakajiri S; Yokoyama M; Tsuyama N; Ishikawa Y; Hatake K
Jpn J Clin Oncol; 2012 Aug; 42(8):697-703. PubMed ID: 22701038
[TBL] [Abstract][Full Text] [Related]
48. Chemotherapy with atezolizumab for small cell or neuroendocrine carcinoma of the prostate: A single institution experience.
Wee CE; Costello BA; Orme JJ; Quevedo JF; Pagliaro LC
Prostate; 2021 Sep; 81(13):938-943. PubMed ID: 34254332
[TBL] [Abstract][Full Text] [Related]
49. Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System: The TOPIC-NEC Phase 3 Randomized Clinical Trial.
Morizane C; Machida N; Honma Y; Okusaka T; Boku N; Kato K; Nomura S; Hiraoka N; Sekine S; Taniguchi H; Okano N; Yamaguchi K; Sato T; Ikeda M; Mizuno N; Ozaka M; Kataoka T; Ueno M; Kitagawa Y; Terashima M; Furuse J;
JAMA Oncol; 2022 Oct; 8(10):1447-1455. PubMed ID: 35980649
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of neoadjuvant endocrine therapy in patients with poorly differentiated neuroendocrine carcinoma of the breast: A case report.
Zhang Y; Liu C; Zheng C; Ren Q; Wang Q; Gao X; He Y; Wu J; Chen G; Li X; Ma Z
Medicine (Baltimore); 2020 Oct; 99(43):e22652. PubMed ID: 33120755
[TBL] [Abstract][Full Text] [Related]
51. Familial small cell carcinoma of the ovary.
Martinez-Borges AR; Petty JK; Hurt G; Stribling JT; Press JZ; Castellino SM
Pediatr Blood Cancer; 2009 Dec; 53(7):1334-6. PubMed ID: 19621450
[TBL] [Abstract][Full Text] [Related]
52. Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide in the treatment of small cell carcinoma of the ovary.
Senekjian EK; Weiser PA; Talerman A; Herbst AL
Cancer; 1989 Sep; 64(6):1183-7. PubMed ID: 2475239
[TBL] [Abstract][Full Text] [Related]
53. [Successful treatment of primary small cell neuroendocrine carcinoma of the cervix].
Rasmussen LB; Lindegaard JC; Lund B; Grove A; Fokdal L
Ugeskr Laeger; 2014 Nov; 176(47):. PubMed ID: 25430538
[TBL] [Abstract][Full Text] [Related]
54. Large cell neuroendocrine carcinoma of the cervix: prognostic factors and survival advantage with platinum chemotherapy.
Embry JR; Kelly MG; Post MD; Spillman MA
Gynecol Oncol; 2011 Mar; 120(3):444-8. PubMed ID: 21138780
[TBL] [Abstract][Full Text] [Related]
55. Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung.
Rossi G; Cavazza A; Marchioni A; Longo L; Migaldi M; Sartori G; Bigiani N; Schirosi L; Casali C; Morandi U; Facciolongo N; Maiorana A; Bavieri M; Fabbri LM; Brambilla E
J Clin Oncol; 2005 Dec; 23(34):8774-85. PubMed ID: 16314638
[TBL] [Abstract][Full Text] [Related]
56. Sinonasal inverted papilloma associated with small cell neuroendocrine carcinoma: A case report and literature review of rare malignancies associated with inverted papilloma.
Nakamura Y; Suzuki M; Ozaki S; Yokota M; Nakayama M; Hattori H; Inagaki H; Murakami S
Auris Nasus Larynx; 2019 Aug; 46(4):641-650. PubMed ID: 30545727
[TBL] [Abstract][Full Text] [Related]
57. [Efficacy of chemotherapy for clear cell adenocarcinoma of the ovary].
Okubo T; Takeda S; Ikeba K; Takagi Y; Ishihara O; Seki H; Kinoshita K
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1279-83. PubMed ID: 9279347
[TBL] [Abstract][Full Text] [Related]
58. Small-cell neuroendocrine carcinoma of the uterine cervix with pancreatic metastasis: a case report and a review of the literature.
Lee EJ; Hwang J; Kim DW
J Obstet Gynaecol; 2019 May; 39(4):573-575. PubMed ID: 30744460
[No Abstract] [Full Text] [Related]
59. [Case of primary hepatic neuroendocrine carcinoma diagnosed by needle biopsy].
Hasegawa H; Kuzushita N; Nakazuru S; Itoh M; Araki M; Yoshioka C; Suemura S; Ohta M; Yoshio T; Toyama T; Ikura Y; Mita E
Nihon Shokakibyo Gakkai Zasshi; 2010 Dec; 107(12):1956-62. PubMed ID: 21139365
[TBL] [Abstract][Full Text] [Related]
60. [An elderly patient with large cell neuroendocrine carcinoma(LCNEC)for whom chemotherapy with irinotecan and split-dose cisplatin(CDDP)proved very effective].
Tanno S; Onodera H; Inoue S; Honda R; Nagashima K; Ohsaki Y
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1205-8. PubMed ID: 24047780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
